Company profile for ASEP Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ASEP consolidates two development-stage companies, Sepset Bioscience and ABT Innovations, with shared missions, founders and investors. Our purpose is to mitigate the global crisis of antibiotic failure by improving patients’ odds of survival and quality of life. Together, our diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnosis and uniquely effective trea...
ASEP consolidates two development-stage companies, Sepset Bioscience and ABT Innovations, with shared missions, founders and investors. Our purpose is to mitigate the global crisis of antibiotic failure by improving patients’ odds of survival and quality of life. Together, our diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnosis and uniquely effective treatment.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
420 – 730 View Street Victoria, BC V8W 3Y7
Telephone
Telephone
+1 778-600-0509
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/asep-medical-featured-in-national-documentary-302212094.html

PR NEWSWIRE
01 Aug 2024
Asep Medical Confirms the Use of AI
Asep Medical Confirms the Use of AI

13 Mar 2024

// PR NEWSWIRE

https://www.prnewswire.com/news-releases/asep-medical-confirms-the-use-of-ai---enables-improved-treatments-for-common-biofilm-infections-and-rapid-sepsis-diagnostics-302088727.html

PR NEWSWIRE
13 Mar 2024

https://www.prnewswire.com/news-releases/asep-medicals-sepsis-diagnostic-technology-can-provide-improved-odds-for-pediatric-appendicitis-302073431.html

PR NEWSWIRE
27 Feb 2024

https://www.prnewswire.com/news-releases/asep-medical-holdings-inc-is-granted-patent-approval-for-its-ai-based-sepsis-diagnostic-technology-in-the-us-301997372.html

PR NEWSWIRE
24 Nov 2023

https://www.prnewswire.com/news-releases/asep-inc-receives-grant-from-nanomedicines-innovation-network-nmin-funded-by-the-government-of-canada-301861325.html

PR NEWSWIRE
23 Jun 2023

https://www.prnewswire.com/news-releases/asep-inc-announces-ground-breaking-ai-technology-for-rapid-identification-of-severe-sepsis-and-improved-superbug-therapies-301841707.html

PR NEWSWIRE
02 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty